Breadcrumb

The RI-MUHC, in collaboration with the three major pediatric research centers in Quebec, are pleased to present the new edition of the Congrès Mère-Enfant...
RI-MUHC researcher Julia Burnier heads one of two projects selected for funding by Moderna
RI-MUHC ANNUAL REPORT 2023YOUR SUPPORTTogether, we have the means to leverage discoveries that improve the health of patients across their...
RI-MUHC ANNUAL REPORT 2023BUSINESS DEVELOPMENT ACTIVITIESCOLLABORATING WITH INDUSTRY TO DEVELOP LIPID NANOPARTICLESJulia Burnier’s project...
RI-MUHC ANNUAL REPORT 2023BUSINESS DEVELOPMENT ACTIVITIESPARTNERING WITH INDUSTRY TO DEVELOP LIPID NANOPARTICLESJulia Burnier’s project...
Dr. Abhinav Sharma will join a prestigious group focused on digital health and cardiovascular disease
Capture and Optimization of Research Data (CORD) UnitThe Capture and Optimization of Research Data (CORD) unit is an integral component of...
The MUHC Vaccine Study Centre has been conducting top quality vaccine and epidemiological research studies for more than 30 years
The RI-MUHC led a one-hour webinar to explore the perspectives of LGBTQIA2S+ people in the research space
An RI-MUHC study suggests that lung development in early life has an impact on the risk of premature death
The PALACE study, an international research endeavour, has evaluated a safer and simpler approach to penicillin allergy testing
A team of RI-MUHC researchers is developing DNA biomarkers to better pinpoint treatment options for patients with prostate cancer
For Tania Janaudis-Ferreira, health outcomes research begins with meaningful patient partnership
Location:   Cruess Amphitheatre, Block E, and the McConnell Atrium
Always on the lookout for major developments in electrophysiology, MUHC clinical teams work closely with research teams at the RI-MUHC to offer the most innovative treatments to patients
The Meakins-Christie Laboratories joined the Translational Research in Respiratory Diseases Program for an inspiring celebration of respiratory research...
See past events
During the Quebec Week for Persons with Disabilities, two people joined research and administrative teams for a daylong internship
Results of an international clinical trial confirm the efficiency of an immunotherapy treatment for early stage non-small cell lung cancer
Location: Hybrid – Virtual and In Person
Whole workflow for flow cytometry and singe cell RNA sequencing
The launch of the Centre for Applied Nanomedicine at the RI-MUHC opens an ecosystem of possibilities to the research community
RI-MUHC researchers and trainees collaborate on four winning teams
Wesal Elgretli’s M.Sc. project underlines the importance of addressing liver disease simultaneously with HCV infection
The RI-MUHC joins the commemoration of the Pride month, an opportunity to understand the realities of LGBTQIA2S+...